Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christine Waterkeyn"'
Autor:
Hélène Cavé, Jutte van der Werff ten Bosch, Stefan Suciu, Christine Guidal, Christine Waterkeyn, Jacques Otten, Marleen Bakkus, Kris Thielemans, Bernard Grandchamp, Etienne Vilmer, Brigitte Nelken, Martine Fournier, Patrick Boutard, Emmanuel Lebrun, Françoise Méchinaud, Richard Garand, Alain Robert, Nicole Dastugue, Emmanuel Plouvier, Evelyne Racadot, Alice Ferster, Jan Gyselinck, Odile Fenneteau, Michel Duval, Gabriel Solbu, Anne-Marie Manel
Publikováno v:
New England Journal of Medicine. 339:591-598
Background and Methods The implications of the detection of residual disease after treatment of acute lymphoblastic leukemia (ALL) are unclear. We conducted a prospective study at 11 centers to determine the predictive value of the presence or absenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d284e587576ef239cf60fb2a451d014
https://doi.org/10.1056/nejm199808273390904
https://doi.org/10.1056/nejm199808273390904
Autor:
Marie-Françoise Dresse, Geneviève Marguerite, Lucilia Norton, Françoise Mazingue, Jacques Otten, Antoine Thyss, Xavier Rialland, Yves Benoit, Anne Uyttebroeck, Alina Ferster, Christine Waterkeyn, Stefan Suciu, N Philippe, Patrick Boutard, Etienne Vilmer, Patrick Lutz, C Behar, Francoise Mechinaud, Alain Robert, Emmanuel Plouvier, N. Francotte, Frédéric Millot
Publikováno v:
Blood. 95:2729-2729
We read with interest the paper of Dordelmann et al[1][1] on prednisone (PDN) response as the strongest predictor value of outcome in infant acute lymphoblastic leukemia (ALL). Between June 1989 and November 1998, 60 (3.1%) infants, among 1963 childr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02eb9bc4e0efea80e19422cb2ad2e58b
https://doi.org/10.1182/blood.v95.8.2729
https://doi.org/10.1182/blood.v95.8.2729
Publikováno v:
Biochemical Pharmacology. 32:2543-2548
Binding on/in whole cells seems to be a more appropriate approach for studying receptor sites in physiological conditions. However, certain difficulties encountered throughout the characterization of [3H]spiperone binding in human lymphocytes led us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c29ca068ff78832decdf75900d54ccfc
https://doi.org/10.1016/0006-2952(83)90016-3
https://doi.org/10.1016/0006-2952(83)90016-3
Autor:
Yves-Jacques Schneider, Christine Waterkeyn, Willem Meuldermans, André Trouet, Pierre M. Laduron
Publikováno v:
Biochemical pharmacology. 36(23)
When incubated with 3H-astemizole, a potent antagonist of H1 receptor, cultured rat hepatocytes, which do not express specific receptors for this ligand, avidly take up 3H-label proportionally to the drug concentration. HPLC analysis indicates that a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7bc425528177c7a9fe81c456afd98ab
https://pubmed.ncbi.nlm.nih.gov/3120732
https://pubmed.ncbi.nlm.nih.gov/3120732